ProfileGDS5822 / ILMN_2573090
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 51% 57% 46% 62% 43% 61% 74% 67% 61% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 122.551
GSM1276600PDAC Late Ablation Control 228.957
GSM1276601PDAC Late Ablation Control 317.746
GSM1276602PDAC Late Ablation 127.862
GSM1276603PDAC Late Ablation 219.743
GSM1276604PDAC Late Ablation 333.961
GSM1303940PDAC Late Ablation_anti-CTLA4 16874
GSM1303941PDAC Late Ablation_anti-CTLA4 253.667
GSM1303942PDAC Late Ablation_anti-CTLA4 338.661